Rocket Pharmaceuticals, Inc. (RCKT)
NASDAQ: RCKT · Real-Time Price · USD
3.430
-0.060 (-1.72%)
At close: Apr 28, 2026, 4:00 PM EDT
3.509
+0.079 (2.31%)
After-hours: Apr 28, 2026, 7:59 PM EDT
Rocket Pharmaceuticals Stock Forecast
RCKT's stock price has decreased by -52.56% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 13 analysts with 12-month price forecasts for Rocket Pharmaceuticals stock have an average target of 29.73, with a low estimate of 2.50 and a high estimate of 263. The average target predicts an increase of 766.76% from the current stock price of 3.43.
Analyst Consensus: Buy
* Price targets were last updated on Mar 30, 2026.
Analyst Ratings
The average analyst rating for Rocket Pharmaceuticals stock from 14 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Hold | 5 | 5 | 5 | 5 | 4 | 4 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 1 | 1 |
| Total | 14 | 14 | 14 | 14 | 14 | 14 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| B of A Securities | B of A Securities | Strong Buy Maintains $8 → $9 | Strong Buy | Maintains | $8 → $9 | +162.39% | Mar 30, 2026 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $11 | Strong Buy | Maintains | $11 | +220.70% | Mar 27, 2026 |
| Goldman Sachs | Goldman Sachs | Strong Sell Maintains $2 → $3 | Strong Sell | Maintains | $2 → $3 | -12.54% | Mar 2, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $8 → $10 | Buy | Maintains | $8 → $10 | +191.55% | Feb 27, 2026 |
| B of A Securities | B of A Securities | Strong Buy Maintains $10 → $8 | Strong Buy | Maintains | $10 → $8 | +133.24% | Nov 18, 2025 |
Financial Forecast
Revenue This Year
14.85M
Revenue Next Year
24.40M
from 14.85M
Increased by 64.28%
EPS This Year
-1.47
from -2.01
EPS Next Year
-1.35
from -1.47
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 150.2M | 136.5M | ||||||
| Avg | 14.9M | 24.4M | ||||||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | - | 819.2% | ||||||
| Avg | - | 64.3% | ||||||
| Low | - | - |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | -0.07 | -0.84 | ||||||
| Avg | -1.47 | -1.35 | ||||||
| Low | -1.79 | -1.89 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | - | - | ||||||
| Avg | - | - | ||||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.